Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.98 USD | -1.63% | +2.00% | -23.32% |
Financials (USD)
Sales 2024 * | 22.82M | Sales 2025 * | 186M | Capitalization | 2.12B |
---|---|---|---|---|---|
Net income 2024 * | -274M | Net income 2025 * | -218M | EV / Sales 2024 * | 84.1 x |
Net cash position 2024 * | 200M | Net cash position 2025 * | 126M | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
-8.09
x | P/E ratio 2025 * |
-12
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.69% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -1.63% | ||
1 week | +2.00% | ||
Current month | +6.78% | ||
1 month | -5.78% | ||
3 months | -21.46% | ||
6 months | +17.42% | ||
Current year | -23.32% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 22.98 | -1.63% | 595,164 |
24-05-07 | 23.36 | +0.69% | 692,507 |
24-05-06 | 23.2 | -1.15% | 424,991 |
24-05-03 | 23.47 | +3.07% | 630,425 |
24-05-02 | 22.77 | +1.07% | 441,516 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.32% | 2.12B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- RCKT Stock